Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Multicenter Non-interventional Study to Investigate Drug Utilization of Pomalidomide in Clinical Practice for the Treatment of Relapsed/Refractory Multiple Myeloma (rrMM)

NCT02555839 is registered in ClinicalTrials.gov with Celgene as lead sponsor.

NCT NCT02555839
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02555839 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Multicenter Non-interventional Study to Investigate Drug Utilization of Pomalidomide in Clinical Practice for the Treatment of Relapsed/Refractory Multiple Myeloma (rrMM)
Lead sponsor
Celgene
Phase
Observational
Overall status
Completed
Start date
February 20, 2015
Completion date
June 30, 2023
Enrollment
127 (actual)
Sites
13

Conditions

As the registry lists them; a condition with its own page is linked.

multiple myeloma